Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
203.80
USD
-0.02 (-0.01%)
Streaming Delayed Price
Updated: 11:17 AM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today
February 11, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Swiss biopharma AC Immune has released positive updates this week on both...
Tags
JNJ
LLY
ACIU
From
InvestorPlace
4 Top COVID Stocks to Buy in February
February 11, 2021
Are you a high-risk stock picker or cautious investor? No matter your answer, there's a stock for you on this list.
Tags
GILD
LLY
REGN
From
Motley Fool
How Risky Are These Heavily Shorted COVID Stocks?
February 11, 2021
These biotech companies may be among the winners of the coronavirus treatment race -- if all goes well in clinical trials.
Tags
GME
Market News
VIR
From
Motley Fool
3 Reasons Pfizer's Failures Could Lead to a Big Acquisition
February 11, 2021
A huge pivot could reopen doors to growth that seemed closed.
Tags
GILD
LLY
REGN
From
Motley Fool
How IPO Stock AbCellera Biologics Shattered Records On Its Way To Profitability
February 10, 2021
IPO stock AbCellera Biologics shattered records in June when it began testing of an antibody-based Covid-19 treatment in just 90 days. Now it shows signs of making waves in the stock market
From
Investor's Business Daily
IPO Stock AbCellera Nears Breakout After Lilly-Partnered Covid Drug Nabs OK
February 10, 2021
Shares of IPO stock AbCellera Biologics rocketed Wednesday after its Eli Lilly-partnered Covid-19 treatment nabbed a Food and Drug Administration second emergency use authorization.
From
Investor's Business Daily
Eli Lilly Doesn't Plan To Claw Back Past Pay From Former CFO - WSJ
February 10, 2021
According to Wall Street Journal,Eli Lilly And Co’s(NYSE:LLY) said it wouldn’t try toclaw back ...
Tags
Market News
News
General
From
Benzinga
The Daily Biotech Pulse: Lilly COVID-19 Antibody Cocktail Approved for Emergency Use, Gamida, Genfit Jump On Data, 2 IPOs
February 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
LABP
SQZ
SLRX
From
Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
February 10, 2021
Eli Lilly’s antibody treatments have received an emergency use authorization from the United States Food and Drug Administration.
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Junshi/Lilly Dual Antibody Treatment Approved in US to Treat COVID-19
February 10, 2021
Junshi Biosciences and Eli Lilly announced their dual mAb treatment was approved in the US to treat COVID-19 under emergency use rules. In a US Phase II/III trial, a combination of Junshi's etesevimab...
From
ChinaBio® Today
A Peek Into The Markets: US Stock Futures Rise; GM, Coca-Cola Earnings In Focus
February 10, 2021
Pre-open movers U.S. stock futures traded higher in early pre-market trade after closing slightly lower in the previous session. ...
Tags
Pre/Market Outlook
Market News
GM
From
Benzinga
Eli Lilly Antibody Drug Combo For COVID-19 Gets FDA Emergency Approval
February 10, 2021
Eli Lilly and Co (NYSE: LLY)’s antibody treatments have received an emergency use authorization from the United States Food and ...
Tags
Biotech
Antibodies
LLY
From
Benzinga
What's Behind Incyte's Better-Than-Expected Q4 Earnings
February 09, 2021
Several products contributed to the biotech's solid growth.
Tags
Market News
INCY
NVS
From
Motley Fool
Eli Lilly's CFO To Step Down Amid Inappropriate Employee Relationship Allegations
February 09, 2021
Eli Lilly And Co's(NYSE:LLY) Chief Financial OfficerJosh Smiley resignedafter an independent ...
Tags
Market News
News
General
From
Benzinga
Barron's Picks And Pans: Amazon, Biogen, Casey's General Stores, Hilton And More
February 06, 2021
This weekend's Barron's cover story discusses a coming Alzheimer's crisis. Other featured articles discuss whether ...
Tags
duke realty
Market News
Hilton Worldwide
From
Benzinga
Week In Review: Junshi Signs $1.1 Billion Deal For US-Canada Rights To PD-1
February 06, 2021
Shanghai Junshi Bio out-licensed US-Canada rights for its anti-PD-1 antibody to Coherus Bio in an agreement worth up to $1.1 billion. Syapse closed a $68 million growth equity investment led by...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Week in Review: Junshi Signs $1.1 Billion Deal for US-Canada Rights to PD-1
February 06, 2021
Deals and Financings Shanghai Junshi Bio out-licensed US-Canada rights for its PD-1 antibody to Coherus Bio in an agreement worth up to $1.1 billion including $150 million upfront; Junshi will make...
From
ChinaBio® Today
Pharma ETFs in Focus Post Q4 Earnings
February 05, 2021
The slew of Q4 results has led to mixed trading in pharma ETFs over the past 10 days. Here is a highlight of those in detail.
Tags
Healthcare
ETFs
From
Blogs - TalkMarkets
10 Health Care Stocks With Unusual Options Alerts In Today's Session
February 04, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ...
Tags
General
TLRY
JNJ
From
Benzinga
10 Biggest Price Target Changes For Thursday
February 04, 2021
SVB Leerink lifted AbbVie Inc (NYSE: ABBV) price target from $128 to $140. AbbVie shares gained 0.7% to $107.65 in pre-market ...
Tags
BIIB
Price Target
LLY
From
Benzinga
1 Major Problem for the Healthcare Industry
February 04, 2021
One company's obstacle is another company's opportunity.
Tags
Market News
CVS
MDT
From
Motley Fool
Can This Maverick Biotech Become the Frontrunner in the Fight Against Alzheimer's?
February 04, 2021
Investors are betting this underdog will succeed where even the most reputable of biotech firms have failed.
Tags
LLY
MRK
BIIB
From
Motley Fool
If you want to avoid Alzheimer’s, try doing these things
February 03, 2021
Why has our understanding of this disease advanced so little?
Tags
LLY
BIIB
From
MarketWatch
Innovent's PD-1 Approved in China for First-Line NSCLC Indication
February 03, 2021
Suzhou Innovent Biologics and its partner Eli Lilly announced China approved its supplemental NDA of their partnered anti-PD-1 drug, Tyvyt® (sintilimab injection), as a first-line treatment for...
From
ChinaBio® Today
2 Growth Stocks for In-the-Know Investors
February 03, 2021
Right now, most investors are oblivious to OptimizeRX and eXp World Holdings. Here's why you should know their names.
Tags
LLY
SNY
Market News
From
Motley Fool
Eli Lilly, Innovent Biologics' Sintilimab Injection Receives China Approval For A Type Of Lung Cancer
February 03, 2021
Eli Lilly and Company(NYSE:LLY) and its collaborating partnerInnovent Biologics Inc(OTC: IVBXF) has announced ...
Tags
Benzinga
Market News
IVBXF
From
Benzinga
FAANGs' Final Fling: Amazon, Alphabet Wrap Up Earnings Season For "Mega-Caps" Later Today
February 02, 2021
The big story last week was a dramatic spike involatility. Today, that appears to be unwinding quickly, perhaps lending some ...
Tags
Apple Inc/
LLY
United Parcel Service
From
Benzinga
Forget Day Trading! Buy and Hold These 2 Stocks
February 02, 2021
They've consistently beaten the market in recent years and they're still growing.
Tags
FB
LLY
Market News
From
Motley Fool
3 Recent Earnings Stocks Worth Buying Today
January 31, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>These three recent earnings stocks are looking stronger than ever both...
Tags
CVX
LLY
INTC
From
InvestorPlace
The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs, And More
January 30, 2021
Biotech stocks alternated between gains and losses in the week ended Jan. 29 before ending lower. Big pharma earnings season kick started, with Novartis AG, Johnson & Johnson, and Eli Lilly And Co all...
Tags
Healthcare
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.